BEIJING, Feb. 14, 2017 /PRNewswire/ -- China Biologic
Products, Inc. (NASDAQ: CBPO)
("China Biologic" or the "Company"), a leading fully
integrated plasma-based biopharmaceutical company in China, today announced that the Company plans
to release fourth quarter and Fiscal Year 2016 financial results on
Thursday, February 23, 2017 after the
market closes.
The Company's management will hold a conference call at
7:30 a.m. ET on Friday, February 24, 2017, which is 8:30 p.m., Beijing Time on February 24, 2017, to discuss fourth quarter and
fiscal year 2016 results. Listeners may access the call by
dialing:
US:
|
1 888 346
8982
|
International:
|
1 412 902
4272
|
Hong
Kong:
|
800 905
945
|
China:
|
400 120
1203
|
A telephone replay will be available one hour after the
conclusion of the conference call through March 3, 2017. The dial-in details are:
US:
|
1 877 344
7529
|
International:
|
1 412 317
0088
|
Passcode:
|
10101712
|
A live and archived webcast of the conference call will be
available through the Company's investor relations website at
http://chinabiologic.investorroom.com/.
About China Biologic Products, Inc.
China Biologic is a leading plasma-based biopharmaceutical
company in China. The Company's
products are used as critical therapies during medical emergencies
and for the prevention and treatment of life-threatening diseases
and immune-deficiency related diseases. China Biologic is
headquartered in Beijing and
manufactures over 20 different dosages of plasma-based products
through its majority-owned subsidiary, Shandong Taibang Biological
Products Co., Ltd., and its wholly-owned subsidiary, Guizhou
Taibang Biological Products Co., Ltd. The Company also has an
equity investment in Xi'an Huitian Blood Products Co., Ltd. The
Company sells its products to hospitals and inoculation centers, as
well as distributors, in China.
For additional information, please see the Company's website,
www.chinabiologic.com.
Contact:
China Biologic Products, Inc.
Mr. Ming Yin
Senior Vice President
Phone: +86-10-6598-3099
Email: ir@chinabiologic.com
ICR Inc.
Mr. Bill Zima
Phone: +86-10-6583-7511 or +1-646-405-5191
E-mail: william.zima@icrinc.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/china-biologic-products-to-report-fourth-quarter-and-fiscal-year-2016-financial-results-300406894.html
SOURCE China Biologic Products, Inc.